CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 466 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01097005
NCT01097005N/ACompleted
CompareCT.gov

Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Mylan Inc.·observational·Posted Apr 1, 2010·Updated Mar 31, 2022

In Brief

An observational study for Mycobacterium Infections, Atypical. Completed, enrolled 466 participants across 59 sites.

Detailed Summary

To evaluate the efficacy and safety of long-term treatment with clarithromycin in patients with Non-tuberculous Mycobacterial Pulmonary Infections.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMycobacterium Infections, Atypical
CountriesJapan
CollaboratorsTaisho Pharmaceutical Co., Ltd.

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 1, 2010
Enrollment StartJan 1, 2009
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 16.3 years ago